|
Drug Topics
Community
Pharmacists' Report
DrugTopics.com
March 13, 2012 |
LEGISLATIVE ACTION
The National Community Pharmacists Association applauded U.S. Congressional representatives for seeking a hearing on the role of pharmacy benefit managers in Medicare Part D. » More
|
CONTINUING EDUCATION
Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
|
FDA NEWS
The FDA’s Center for Drug Evaluation and Research released a new draft guidance on how it develops and classifies drug-safety issues. » More
|
|
FDA approved a dose counter for use with albuterol sulfate (ProAir HFA, Teva Respiratory) for prevention of bronchospasm, the company announced. » More
|
CHAINS AND BUSINESS
The Colon Cancer Alliance and makers of Dulcolax products are working together again to remind people that March is Colorectal Cancer Awareness Month and to urge them to schedule a screening. » More
|
|
Pharmacists are already getting more heavily involved in medication therapy management and counseling services. Now, a company is also urging them to offer patients nutritional guidance as well. » More
|
|
David D. Pope, PharmD, CDE and editor in chief of CreativePharmacist.com, has created another online tool to help pharmacists work with the overall healthcare of their patients.
» More
|
MEETINGS
The International Pharmaceutical Federation will celebrate its 100th anniversary at the Centennial Congress of Pharmacy and Pharmaceutical Sciences, scheduled October 3 through 8 in Amsterdam, The Netherlands. » More
|
Survey
a) Yes, my employer allows PharmD after my name or the use of the title Dr. before my name.
b) Yes, my employer allows PharmD after my name but not the title Dr. before my name.
c) No, my employer does not allow any doctor title before or after my name.
Respond here and see what your colleagues think, too.
Want to see the results of our last survey about whether pharmacists should have the authority to prescribe medications? Click here.
|
|
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|
